FdaApplication
ANDA 215765
Identifiers
- fda_app_no: ANDA215765
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT VI |
| application_type | ANDA |
| approval_date | 2024-10-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS |
1 product